GlassScriptPhysician profile
Philip M Watkins
NPI 1811342421
$6,465.61
in general payments reported to CMS, 2019-2025
24 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,132 · 2020: $926 · 2021: $573 · 2022: $1,716 · 2023: $441 · 2024: $188 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,471.59 | 2019-2023 | |
| Stryker Corporation | $1,362.16 | 2019-2025 | Prostep, Actishield, Alphavent |
| Paragon 28, INC. | $683.68 | 2019-2022 | |
| Organogenesis INC. | $346.52 | 2020-2025 | Puraply Wound Matrix, Apligraf, Puraply Am |
| Smith+Nephew, INC. | $269.43 | 2019-2022 | |
| Integra Lifesciences Corporation | $167.35 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Misonix INC | $164.41 | 2020 | |
| Acumed LLC | $154.37 | 2021-2024 | Osteomed |
| Cardiovascular Systems INC. | $108.35 | 2020 | |
| Kerecis Limited | $101.73 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Orthofix Medical, INC. | $92.84 | 2020-2025 | Physio-Stim, Spinal-Stim |
| Zimmer Biomet Holdings, INC. | $87.17 | 2019-2020 | |
| Averitas Pharma INC. | $74.74 | 2023-2024 | Qutenza |
| Abbott Laboratories | $72.29 | 2024-2025 | Proclaim |
| Anika Therapeutics, INC. | $61.03 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $59.53 | 2019-2022 | |
| Horizon Therapeutics Plc | $35.92 | 2022-2023 | Krystexxa |
| Polynovo North America LLC | $27.63 | 2024 | Novosorb Btm |
| Convatec INC. | $27.61 | 2021 | |
| Grt US Holding, INC. | $25.51 | 2021 | |
| Arthrosurface Incorporated | $25.17 | 2019-2020 | |
| Abbvie INC. | $16.60 | 2024 | |
| Linvatec Corporation | $15.02 | 2022 | |
| Mimedx Group, INC. | $14.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Watkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.